Literature DB >> 9715267

Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes.

B D Humphreys1, G R Dubyak.   

Abstract

Regulation of P2X7 receptor expression is of interest because activation of this receptor by extracellular ATP triggers maturation and release of the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) in monocytes and macrophages. We report that interferon-gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) synergistically induce P2X7R mRNA and functional responses in the human THP-1 monocytic cell line. Induction was dose dependent, with maximal functional activity requiring 1000 units/mL IFN-gamma and 10 ng/mL TNF-alpha and incubations of 36-72 h. The up-regulation of P2X7R function by lipopolysaccharide (LPS)/IFN-gamma and TNF-alpha/IFN-gamma was markedly attenuated by coincubation with prostaglandin E2 or the cell permeant cyclic AMP analog dibutryl cAMP (Bt2cAMP). Bt2cAMP did not significantly alter P2X7 function in HEK-293 cells stably transfected with the human P2X7 cDNA, indicating that Bt2cAMP does not exert a generalized effect on P2X7R synthesis or downstream signal transduction. These studies demonstrate that elevated cAMP negatively modulates P2X7R expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715267     DOI: 10.1002/jlb.64.2.265

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  49 in total

1.  Mutation of putative N-linked glycosylation sites on the human nucleotide receptor P2X7 reveals a key residue important for receptor function.

Authors:  Lisa Y Lenertz; Ziyi Wang; Arturo Guadarrama; Lindsay M Hill; Monica L Gavala; Paul J Bertics
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

2.  Synergic effects of mycoplasmal lipopeptides and extracellular ATP on activation of macrophages.

Authors:  Takeshi Into; Mari Fujita; Tsugumi Okusawa; Akira Hasebe; Manabu Morita; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules.

Authors:  Gloria Lopez-Castejón; Alberto Baroja-Mazo; Pablo Pelegrín
Journal:  Cell Mol Life Sci       Date:  2010-12-28       Impact factor: 9.261

4.  P2 receptors in renal pathophysiology.

Authors:  Clare M Turner; James I Elliott; Frederick W K Tam
Journal:  Purinergic Signal       Date:  2009-06-09       Impact factor: 3.765

5.  The role of P2 receptors in controlling infections by intracellular pathogens.

Authors:  Robson Coutinho-Silva; Cristiane Monteiro da Cruz; Pedro M Persechini; David M Ojcius
Journal:  Purinergic Signal       Date:  2007-01-12       Impact factor: 3.765

6.  Block of P2X7 receptors could partly reverse the delayed neuronal death in area CA1 of the hippocampus after transient global cerebral ischemia.

Authors:  Qiang Yu; Zhili Guo; Xiaofeng Liu; Qing Ouyang; Cheng He; Geoffrey Burnstock; Hongbin Yuan; Zhenghua Xiang
Journal:  Purinergic Signal       Date:  2013-07-23       Impact factor: 3.765

7.  Two different ionotropic receptors are activated by ATP in rat microglia.

Authors:  S Visentin; M Renzi; C Frank; A Greco; G Levi
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

8.  P2X(7) Receptors in Neurological and Cardiovascular Disorders.

Authors:  Stephen D Skaper; Patrizia Debetto; Pietro Giusti
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-06-24

9.  P2X(7) Receptors as a Transducer in the Co-Occurrence of Neurological/Psychiatric and Cardiovascular Disorders: A Hypothesis.

Authors:  Stephen D Skaper; Pietro Giusti
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-10

10.  P2X7R antagonism after subfailure overstretch injury of blood vessels reverses vasomotor dysfunction and prevents apoptosis.

Authors:  Weifeng Luo; Daniel Feldman; Reid McCallister; Colleen Brophy; Joyce Cheung-Flynn
Journal:  Purinergic Signal       Date:  2017-09-13       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.